PFE vs VRT: Which Is the Better Buy?
Side-by-side comparison of Pfizer Inc. and Vertiv Holdings Co — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-18.
Pfizer Inc. · Healthcare
$26.91
+30.1% upside to fair value
Med Conviction
Grade B+
VS
Vertiv Holdings Co · Industrials
$307.34
-11.3% upside to fair value
Grade D
High Quality
QuantHub Verdict
PFE has more upside to fair value
(+30.1%).
PFE trades at a lower forward P/E
(9.5x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
PFE |
VRT |
| Current Price |
$26.91 |
$307.34 |
| Fair Value Estimate |
$35.00 |
$272.65 |
| Upside to Fair Value |
+30.1%
|
-11.3%
|
| Market Cap |
$153.0B |
$117.6B |
| Forward P/E |
9.5x
|
88.2x
|
| EV / EBITDA |
13.8x
|
55.3x
|
| Price / Sales |
2.4x
|
11.5x
|
| Price / FCF |
16.8x
|
61.2x
|
| Revenue Growth YoY |
-1.6%
|
+7.6%
|
| Gross Margin |
70.3%
|
34.8%
|
| Operating Margin |
24.7%
|
18.2%
|
| Return on Equity |
9.0%
|
40.3%
|
| Dividend Yield |
6.4% |
0% |
| FCF Yield |
5.9%
|
1.63%
|
| Analyst Consensus |
Hold
|
Strong Buy
|
Investment Thesis
Pfizer remains the world's largest traditional pharmaceutical company by non-COVID revenue, generating $62.6B in 2025 sales across oncology, cardiovascular, immunology, and vaccines. The stock trades at a P/S of 2.44x, still well below the 5-year median of 3.10x, driven by post-COVID revenue normalization, a $17-18B patent cliff spanning 2026-2028, and $61.6B in acquisition-related debt from Seag…
Vertiv Holdings Co operates as a global leader in digital critical infrastructure, providing technology products and solutions primarily for data centers, telecom, and AI-driven markets. The company demonstrates strong business quality with 40.3% return on equity, 7.6% revenue growth, and 11.8% earnings growth year-over-year, supported by a robust $1.89 billion free cash flow and a $15 billion ba…
Accumulation Zones
| Metric |
PFE |
VRT |
| Zone Low |
$25.00 |
$204.49 |
| Zone High |
$29.00 |
$231.75 |
| In Buy Zone? |
Yes
|
No
|